Literature DB >> 22925431

The study of pathogen resistance and antimicrobial use in dementia: study design and methodology.

Susan L Mitchell1, Michele L Shaffer, Dan K Kiely, Jane L Givens, Erika D'Agata.   

Abstract

Advanced dementia is characterized by the onset of infections and antimicrobial use is extensive. The extent to which this antimicrobial use is appropriate and contributes to the emergence of antimicrobial resistant bacteria is not known. The object of this report is to present the methodology established in the Study of Pathogen Resistance and Exposure to Antimicrobials in Dementia (SPREAD), and describe how challenges specific to this research were met. SPREAD is an ongoing, federally funded, 5-year prospective cohort study initiated in September 2009. Subjects include nursing home residents with advanced dementia and their proxies recruited from 31 Boston-area facilities. The recruitment and data collection protocols are described. Characteristics of participant facilities are presented and compared to those nationwide. To date, 295 resident/proxy dyads have been recruited. Baseline and selected follow-up data demonstrate successful recruitment of subjects and repeated collection of complex data documenting infections, decision-making for these infections, and antimicrobial bacteria resistance among the residents. SPREAD integrates methods in dementia, palliative care and infectious diseases research. Its successful implementation further establishes the feasibility of conducting rigorous, multi-site NH research in advanced dementia, and the described methodology serves as a detailed reference for subsequent publications emanating from the study.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22925431      PMCID: PMC3502703          DOI: 10.1016/j.archger.2012.08.001

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  36 in total

1.  High short-term mortality in hospitalized patients with advanced dementia: lack of benefit of tube feeding.

Authors:  D E Meier; J C Ahronheim; J Morris; S Baskin-Lyons; R S Morrison
Journal:  Arch Intern Med       Date:  2001-02-26

2.  Prevalence of ceftriaxone- and ceftazidime-resistant gram-negative bacteria in long-term-care facilities.

Authors:  L Mody; S F Bradley; L J Strausbaugh; R R Muder
Journal:  Infect Control Hosp Epidemiol       Date:  2001-04       Impact factor: 3.254

3.  Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: prevalence and predictors of colonization in patients presenting to the emergency department from nursing homes.

Authors:  David C Lee; David Barlas; James G Ryan; Mary F Ward; Andrew E Sama; Bruce F Farber
Journal:  J Am Geriatr Soc       Date:  2002-08       Impact factor: 5.562

4.  Resistant pathogens: considerations in geriatrics and infectious disease.

Authors:  Thomas T Yoshikawa
Journal:  J Am Geriatr Soc       Date:  2002-07       Impact factor: 5.562

Review 5.  Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference.

Authors:  M Loeb; D W Bentley; S Bradley; K Crossley; R Garibaldi; N Gantz; A McGeer; R R Muder; J Mylotte; L E Nicolle; B Nurse; S Paton; A E Simor; P Smith; L Strausbaugh
Journal:  Infect Control Hosp Epidemiol       Date:  2001-02       Impact factor: 3.254

6.  Colonization of skilled-care facility residents with antimicrobial-resistant pathogens.

Authors:  W E Trick; R A Weinstein; P L DeMarais; M J Kuehnert; W Tomaska; C Nathan; T W Rice; S K McAllister; L A Carson; W R Jarvis
Journal:  J Am Geriatr Soc       Date:  2001-03       Impact factor: 5.562

7.  Survival in end-stage dementia following acute illness.

Authors:  R S Morrison; A L Siu
Journal:  JAMA       Date:  2000-07-05       Impact factor: 56.272

8.  Risk factors for antibiotic-resistant infection and treatment outcomes among hospitalized patients transferred from long-term care facilities: does antimicrobial choice make a difference?

Authors:  E Toubes; K Singh; D Yin; R Lyu; N Glick; L Russell; S Mohapatra; N Saghal; R A Weinstein; G Trenholme
Journal:  Clin Infect Dis       Date:  2003-02-27       Impact factor: 9.079

9.  Antibiotic use in Ontario facilities that provide chronic care.

Authors:  M Loeb; A E Simor; L Landry; S Walter; M McArthur; J Duffy; D Kwan; A McGeer
Journal:  J Gen Intern Med       Date:  2001-06       Impact factor: 5.128

Review 10.  Antimicrobial resistance and aging: beginning of the end of the antibiotic era?

Authors:  Thomas T Yoshikawa
Journal:  J Am Geriatr Soc       Date:  2002-07       Impact factor: 5.562

View more
  14 in total

1.  Healthcare Proxy Awareness of Suspected Infections in Nursing Home Residents with Advanced Dementia.

Authors:  Jane L Givens; Sara Spinella; Claire K Ankuda; Erika D'Agata; Michele L Shaffer; Daniel Habtemariam; Susan L Mitchell
Journal:  J Am Geriatr Soc       Date:  2015-06-01       Impact factor: 5.562

2.  Auranofin is an effective agent against clinical isolates of Staphylococcus aureus.

Authors:  Nagendran Tharmalingam; Noelly Q Ribeiro; Danielle L da Silva; Mandar T Naik; Lana Ib Cruz; Wooseong Kim; Steven Shen; Jéssica D Dos Santos; Katarina Ezikovich; Erika Mc D'Agata; Eleftherios Mylonakis; Beth B Fuchs
Journal:  Future Med Chem       Date:  2019-07-12       Impact factor: 3.808

3.  Acquisition of Multidrug-resistant Organisms in the Absence of Antimicrobials.

Authors:  Erika M C D'Agata; Aby Varu; Sara F Geffert; Rafael Araos; Susan Mitchell; Aaron Situ; Chris Cameron
Journal:  Clin Infect Dis       Date:  2018-10-15       Impact factor: 9.079

4.  Fecal Microbiome Among Nursing Home Residents with Advanced Dementia and Clostridium difficile.

Authors:  Rafael Araos; Nikolaos Andreatos; Juan Ugalde; Susan Mitchell; Eleftherios Mylonakis; Erika M C D'Agata
Journal:  Dig Dis Sci       Date:  2018-03-28       Impact factor: 3.199

5.  Association of Prognostic Estimates With Burdensome Interventions in Nursing Home Residents With Advanced Dementia.

Authors:  Andrea J Loizeau; Michele L Shaffer; Daniel A Habtemariam; Laura C Hanson; Angelo E Volandes; Susan L Mitchell
Journal:  JAMA Intern Med       Date:  2018-07-01       Impact factor: 21.873

6.  Multidrug-Resistant Gram-Negative Bacteria: Inter- and Intradissemination Among Nursing Homes of Residents With Advanced Dementia.

Authors:  Erika M C D'Agata; Daniel Habtemariam; Susan Mitchell
Journal:  Infect Control Hosp Epidemiol       Date:  2015-04-29       Impact factor: 3.254

7.  Infection management and multidrug-resistant organisms in nursing home residents with advanced dementia.

Authors:  Susan L Mitchell; Michele L Shaffer; Mark B Loeb; Jane L Givens; Daniel Habtemariam; Dan K Kiely; Erika D'Agata
Journal:  JAMA Intern Med       Date:  2014-10       Impact factor: 21.873

Review 8.  Examining the relationship between multidrug-resistant organism acquisition and exposure to antimicrobials in long-term care populations: a review.

Authors:  Michele L Shaffer; Erika M C D'Agata; Daniel Habtemariam; Susan L Mitchell
Journal:  Ann Epidemiol       Date:  2016-09-23       Impact factor: 3.797

9.  Survival After Suspected Urinary Tract Infection in Individuals with Advanced Dementia.

Authors:  Alyssa B Dufour; Michele L Shaffer; Erika M C D'Agata; Daniel Habtemariam; Susan L Mitchell
Journal:  J Am Geriatr Soc       Date:  2015-11-28       Impact factor: 5.562

10.  Microbial Disruption Indices to Detect Colonization With Multidrug-Resistant Organisms.

Authors:  Rafael Araos; Veronica Montgomery; Juan A Ugalde; Graham M Snyder; Erika M C D'Agata
Journal:  Infect Control Hosp Epidemiol       Date:  2017-09-13       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.